File size: 7,206 Bytes
e4584d4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
treatment_phases
Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription
Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months)
Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine
"Balance of supply for Initial treatment, Continuing treatment - subcutaneous form"
Continuing Treatment - balance of supply
Continuing or recommencement of treatment (within 12 months of a treatment break)

Continuing treatment
Continuing treatment - balance of supply
Continuing treatment in a patient weighing at least 30 kg
Continuing treatment in a patient weighing less than 30 kg
Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form
First Continuing treatment
First Continuing treatment - balance of supply
First continuing treatment
First continuing treatment - balance of supply
"Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
"Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
"Initial 1 (New patient), Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
Initial treatment
Initial treatment - Initial 1 (New patient)
Initial treatment - Initial 1 (new patient weighing at least 30 kg)
Initial treatment - Initial 1 (new patient weighing less than 30 kg)
Initial treatment - Initial 1 (new patient)
Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply
Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply
"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years)
Initial treatment - Initial 2 (Change or re-commencement of treatment after a break of less than 5 years)
Initial treatment - Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years)
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)
Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing at least 30 kg)
Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing less than 30 kg)
Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months)
Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)
Initial treatment - Initial 3 (recommencement of a new treatment cycle after a break of more than 12 months in a patient weighing less than 30 kg)
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months in a patient weighing at least 30 kg)
Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months)
Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)
Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab)
Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made
Subsequent continuing treatment
Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements